170 related articles for article (PubMed ID: 20490489)
1. Endostatin gene therapy enhances the efficacy of IL-2 in suppressing metastatic renal cell carcinoma in mice.
Rocha FG; Chaves KC; Chammas R; Peron JP; Rizzo LV; Schor N; Bellini MH
Cancer Immunol Immunother; 2010 Sep; 59(9):1357-65. PubMed ID: 20490489
[TBL] [Abstract][Full Text] [Related]
2. Endostatin neoadjuvant gene therapy extends survival in an orthotopic metastatic mouse model of renal cell carcinoma.
de Souza Braga M; Chaves KB; Chammas R; Schor N; Bellini MH
Biomed Pharmacother; 2012 Jun; 66(4):237-41. PubMed ID: 22560459
[TBL] [Abstract][Full Text] [Related]
3. Endostatin gene therapy stimulates upregulation of ICAM-1 and VCAM-1 in a metastatic renal cell carcinoma model.
Chaves KC; Peron JP; Chammas R; Turaça LT; Pesquero JB; Braga MS; Foguer K; Schor N; Bellini MH
Cancer Gene Ther; 2012 Aug; 19(8):558-65. PubMed ID: 22699868
[TBL] [Abstract][Full Text] [Related]
4. Fibronectin expression is decreased in metastatic renal cell carcinoma following endostatin gene therapy.
Chaves KC; Turaça LT; Pesquero JB; Mennecier G; Dagli ML; Chammas R; Schor N; Bellini MH
Biomed Pharmacother; 2012 Sep; 66(6):464-8. PubMed ID: 22920414
[TBL] [Abstract][Full Text] [Related]
5. Endostatin gene therapy inhibits intratumoral macrophage M2 polarization.
Foguer K; Braga Mde S; Peron JP; Bortoluci KR; Bellini MH
Biomed Pharmacother; 2016 Apr; 79():102-11. PubMed ID: 27044818
[TBL] [Abstract][Full Text] [Related]
6. Rapid, in vivo, evaluation of antiangiogenic and antineoplastic gene products by nonviral transfection of tumor cells.
Weiss JM; Shivakumar R; Feller S; Li LH; Hanson A; Fogler WE; Fratantoni JC; Liu LN
Cancer Gene Ther; 2004 May; 11(5):346-53. PubMed ID: 15031722
[TBL] [Abstract][Full Text] [Related]
7. Endostatin- and interleukin-2-expressing retroviral bicistronic vector for gene therapy of metastatic renal cell carcinoma.
Rocha FG; Calvo FB; Chaves KC; Peron JP; Marques RF; de Borba TR; Braga MS; Pereira CB; Vicente EJ; Chammas R; Schor N; Bellini MH
J Gene Med; 2011 Mar; 13(3):148-57. PubMed ID: 21344541
[TBL] [Abstract][Full Text] [Related]
8. Systemic treatment with interleukin-4 induces regression of pulmonary metastases in a murine renal cell carcinoma model.
Hillman GG; Younes E; Visscher D; Ali E; Lam JS; Montecillo E; Pontes JE; Haas GP; Puri RK
Cell Immunol; 1995 Feb; 160(2):257-63. PubMed ID: 7720087
[TBL] [Abstract][Full Text] [Related]
9. Radio frequency ablation combined with interleukin-2 induces an antitumor immune response to renal cell carcinoma in a murine model.
Kroeze SG; Daenen LG; Nijkamp MW; Roodhart JM; de Gast GC; Bosch JL; Jans JJ
J Urol; 2012 Aug; 188(2):607-14. PubMed ID: 22704448
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor as a biomarker for endostatin gene therapy.
Braga MS; Turaça TL; Foguer K; Chaves KC; Pesquero JB; Chammas R; Schor N; Bellini MH
Biomed Pharmacother; 2013 Jul; 67(6):511-5. PubMed ID: 23726969
[TBL] [Abstract][Full Text] [Related]
11. Eradication of metastatic renal cell carcinoma after adenovirus-encoded TNF-related apoptosis-inducing ligand (TRAIL)/CpG immunotherapy.
Norian LA; Kresowik TP; Rosevear HM; James BR; Rosean TR; Lightfoot AJ; Kucaba TA; Schwarz C; Weydert CJ; Henry MD; Griffith TS
PLoS One; 2012; 7(2):e31085. PubMed ID: 22312440
[TBL] [Abstract][Full Text] [Related]
12. In vivo hydrodynamic delivery of cDNA encoding IL-2: rapid, sustained redistribution, activation of mouse NK cells, and therapeutic potential in the absence of NKT cells.
Ortaldo JR; Winkler-Pickett RT; Bere EW; Watanabe M; Murphy WJ; Wiltrout RH
J Immunol; 2005 Jul; 175(2):693-9. PubMed ID: 16002664
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy for lung metastases of murine renal cell carcinoma: synergy between radiation and cytokine-producing tumor vaccines.
Nishisaka N; Maini A; Kinoshita Y; Yasumoto R; Kishimoto T; Jones RF; Morse P; Hillman GG; Wang CY; Haas GP
J Immunother; 1999 Jul; 22(4):308-14. PubMed ID: 10404432
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
Hillman GG; Younes E; Visscher D; Hamzavi F; Kim S; Lam JS; Montecillo EJ; Ali E; Pontes JE; Puri RK; Haas GP
Clin Cancer Res; 1997 Oct; 3(10):1799-806. PubMed ID: 9815566
[TBL] [Abstract][Full Text] [Related]
15. Impact of endostatin gene therapy on myeloid-derived suppressor cells from a metastatic renal cell carcinoma.
Chaves KC; Costa EM; Teixeira LF; Bellini MH
Exp Oncol; 2018 Mar; 40(1):24-32. PubMed ID: 29600976
[TBL] [Abstract][Full Text] [Related]
16. Combination of radiation and vaccination with autologous tumor cells expressing IL-2, IFN-gamma and GM-CSF for treatment of murine renal carcinoma.
Maini A; Nishisaka N; Kinoshita Y; Jones RF; Wang CY; Haas GP
In Vivo; 2003; 17(2):119-23. PubMed ID: 12792971
[TBL] [Abstract][Full Text] [Related]
17. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model.
Liu LL; Smith MJ; Sun BS; Wang GJ; Redmond HP; Wang JH
Ann Surg Oncol; 2009 May; 16(5):1403-11. PubMed ID: 19263173
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the NF-кB/p50/Bcl-3 complex in response to antiangiogenic therapy in a mouse model of metastatic renal cell carcinoma.
de Souza Braga M; da Silva Paiva KB; Foguer K; Barbosa Chaves KC; de Sá Lima L; Scavone C; Bellini MH
Biomed Pharmacother; 2014 Sep; 68(7):873-9. PubMed ID: 25113400
[TBL] [Abstract][Full Text] [Related]
19. Sodium stibogluconate interacts with IL-2 in anti-Renca tumor action via a T cell-dependent mechanism in connection with induction of tumor-infiltrating macrophages.
Fan K; Zhou M; Pathak MK; Lindner DJ; Altuntas CZ; Tuohy VK; Borden EC; Yi T
J Immunol; 2005 Nov; 175(10):7003-8. PubMed ID: 16272361
[TBL] [Abstract][Full Text] [Related]
20. Neutralization of interleukin-2 retards the growth of mouse renal cancer.
Fukuhara H; Matsumoto A; Kitamura T; Takeuchi T
BJU Int; 2006 Jun; 97(6):1314-21. PubMed ID: 16686731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
